SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Chan KH, Cheung RTF, Au-Yeung KM, Mak W, Cheng TS, Ho SL. J. Clin. Neurosci. 2005; 12(3): 303-305.

Copyright

(Copyright © 2005, Elsevier Publishing)

DOI

10.1016/j.jocn.2004.09.005

PMID

15851088

Abstract

Wilson's disease (WD) is an autosomal recessive disorder with reduced biliary excretion of copper plus impaired formation of ceruloplasmin, leading to copper accumulation in the liver, brain, kidney, and cornea. Clinical manifestations include liver damage, psychiatric symptoms, and neurological features. We report a 35-year-old woman with a history of deranged liver functions who had severe depression several years later and eventually presented with parkinsonian features. The underlying diagnosis is WD and family screening revealed WD in 2 other siblings. She could not tolerate penicillamine because of fever and leucopenia. While taking trientine hydrochloride and zinc sulphate, her parkinsonism improved and her depression remained in remission. WD should be considered in patients with unexplained liver function derangement or psychiatric symptoms. Early diagnosis and initiation of specific treatment are crucial in minimising any further cerebral and hepatic damage as well as securing possible improvement in organ functions.


Language: en

Keywords

Adult; Antiparkinson Agents; Brain; Bromocriptine; Chelating Agents; Depressive Disorder; Female; Hepatolenticular Degeneration; Humans; Magnetic Resonance Imaging; Parkinsonian Disorders; Penicillamine; Suicide, Attempted; Tomography, X-Ray Computed; Trientine; Trihexyphenidyl

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print